Aims and Scope of Biomaterials
Biomaterials is a peer-reviewed scientific journal covering research on and applications of biomaterials. It is published by Elsevier and the editor-in-chief is Kam W. Leong (Columbia University). The journal was established in 1980. Less
Key Metrics
CiteScore 

21.5
Eigenfactor 

0.05 - 0.1
H-Index 

418
Impact Factor 

10 - 15
Scite Index 

0.95 5-Year SI

SJR 

Q1Biophysics

SNIP 

2.05
Recommended pre-submission checks
Powered by 

Topics Covered on Biomaterials
Biomaterials Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
Inspec
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 1980 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Biomaterials ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Biomaterials
Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment
- 1 Jan 2027
- Biomaterials
A mechanism-inspired integrated dual-frequency ultrasound transducer for cavitation-enhanced transdermal drug delivery.
- 1 Dec 2026
- Biomaterials
C-di-AMP inhibition-propelled unlocking bacterial cuproptosis accelerates tissue remodeling and confers long-lasting immunoprotection.
- 1 Dec 2026
- Biomaterials
Multifunctional immunomodulator with cascade catalytic activities to reprogram endoplasmic reticulum stress-mediated immunosuppression for enhancing anti-tumor immunotherapy.
- 1 Dec 2026
- Biomaterials
Corrigendum to "Single-cell RNA-seq reveals functionally distinct biomaterial degradation-related macrophage populations" [Biomaterials Oct:277 (2021) 121116
- 1 Dec 2026
- Biomaterials
MOF-based nanoparticles enabling blood-brain barrier crossing for non-invasive selective sononeuromodulation in epilepsy.
- 1 Dec 2026
- Biomaterials
Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment
- 1 Jan 2027
- Biomaterials
A mechanism-inspired integrated dual-frequency ultrasound transducer for cavitation-enhanced transdermal drug delivery.
- 1 Dec 2026
- Biomaterials
C-di-AMP inhibition-propelled unlocking bacterial cuproptosis accelerates tissue remodeling and confers long-lasting immunoprotection.
- 1 Dec 2026
- Biomaterials
Multifunctional immunomodulator with cascade catalytic activities to reprogram endoplasmic reticulum stress-mediated immunosuppression for enhancing anti-tumor immunotherapy.
- 1 Dec 2026
- Biomaterials
Corrigendum to "Single-cell RNA-seq reveals functionally distinct biomaterial degradation-related macrophage populations" [Biomaterials Oct:277 (2021) 121116
- 1 Dec 2026
- Biomaterials
MOF-based nanoparticles enabling blood-brain barrier crossing for non-invasive selective sononeuromodulation in epilepsy.
- 1 Dec 2026
- Biomaterials